Home › Melanoma › Colorado › Denver
Pag-aaral pangklinika para sa Melanoma sa Denver, CO
19 pag-aaral para sa Melanoma ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Denver (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Phase 1 Study of PF-08046033 in Advanced Solid Tumors
Nagre-recruitPhase 1
- Presbyterian/St Lukes Medical Center, Denver
- Sarah Cannon Research Institute at HealthONE, Denver
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
Nagre-recruitPhase 3
- The Melanoma And Skin Cancer Institute, Englewood · 6 mi ang layo
Pan-tumor MRD Study
Nagre-recruitObservasyonal na pag-aaral
- The Melanoma and Skin Cancer Institute, Englewood · 6 mi ang layo
R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune Cells Called T Cells) in Patients With Solid Tumors
Nagre-recruitPhase 1
- Sarah Cannon Research Institute, Denver
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
Nagre-recruitPhase 2
- The Women's Imaging Center, Denver
- Colorado Blood Cancer Institute, Denver
- Presbyterian - Saint Lukes Medical Center - Health One, Denver
- at 6 pa
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
Nagre-recruitPhase 1/2
- Skin Cancer Institute, Englewood · 6 mi ang layo
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- AdventHealth Porter, Denver
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
Nagre-recruitPhase 1
- Sarah Cannon Research Institute Denver, Denver
Project: Every Child for Younger Patients With Cancer
Nagre-recruitObservasyonal na pag-aaral
- Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center, Denver
A Study to Investigate the Safety and Efficacy of IOV-3001 in Adults With Advanced Melanoma Who Will Receive Lifileucel
Nagre-recruitPhase 1/2
- SCRI Oncology Partners- Denver, Denver
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
Nagre-recruitPhase 1/2
- SCRI - Denver, Denver
Neoadjuvant Darovasertib in Primary Uveal Melanoma
Nagre-recruitPhase 3
- The Melanoma and Skin Cancer Institute, Englewood · 6 mi ang layo
A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma
Nagre-recruitPhase 2/3
- University of Colorado, Denver
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
Nagre-recruitPhase 1
- Sarah Cannon Research Institute at Health ONE, Denver
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
Nagre-recruitPhase 2/3
- The Melanoma & Skin Cancer Institute, Englewood · 6 mi ang layo
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Nagre-recruitObservasyonal na pag-aaral
- Kaiser Permanente-Franklin, Denver
- Colorado Blood Cancer Institute, Denver
- Rocky Mountain Cancer Centers-Midtown, Denver
- at 1 pa
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
- Massive Bio SYNERGY-AI site, Denver
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
Nagre-recruitPhase 1/2
- HealthONE Clinic Services Oncology - Hematology, LLC d/b/a Sarah Cannon Research Institute at HealthONE, Denver
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
Nagre-recruitPhase 1/2
- Sarah Cannon Research Institute at HealthONE, Denver
Pag-aaral para sa Melanoma sa ibang lungsod
- Houston, TX59 pag-aaral
- New York City, NY38 pag-aaral
- Los Angeles, CA34 pag-aaral
- Nashville, TN32 pag-aaral
- Pittsburgh, PA31 pag-aaral
- Boston, MA25 pag-aaral
- Philadelphia, PA23 pag-aaral
- San Francisco, CA22 pag-aaral
- Atlanta, GA21 pag-aaral
- Columbus, OH21 pag-aaral
- Salt Lake City, UT21 pag-aaral
- Durham, NC21 pag-aaral
Iba pang pag-aaral sa Denver
- Metastatic Cancer29 pag-aaral
- Kanser sa Suso28 pag-aaral
- Non-Small Cell Lung Cancer27 pag-aaral
- Multiple Myeloma26 pag-aaral
- Colorectal Cancer23 pag-aaral
- Kanser (lahat ng uri)19 pag-aaral
- Kanser sa Prostate19 pag-aaral
- Kanser sa Ovary16 pag-aaral
- Kanser ng Endometrium16 pag-aaral
- Kanser sa Baga16 pag-aaral
- Non-Hodgkin Lymphoma14 pag-aaral
- Kanser sa Pancreas13 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.